Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Chihiro Taka"'
Autor:
Takeshi Tsuda, Tomomi Ichikawa, Masahiro Matsumoto, Isami Mizusihima, Kenji Azechi, Naoki Takata, Nozomu Murayama, Kana Hayashi, Takahiro Hirai, Zenta Seto, Kotaro Tokui, Yasuaki Masaki, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Hirokazu Taniguchi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Minehiko Inomata
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-9 (2024)
Abstract Background Pulmonary sarcomatoid carcinoma is a rare tumor that is resistant to cytotoxic agents. This observational study aimed to evaluate the detection rate of driver gene alteration and the efficacy of targeted therapy for pulmonary sarc
Externí odkaz:
https://doaj.org/article/0daef32daf774bb8b141fae7e8643c1d
Autor:
Minehiko Inomata, Masahiro Matsumoto, Naoki Takata, Kana Hayashi, Zenta Seto, Takahiro Hirai, Kotaro Tokui, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Kazuyuki Tobe
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Immune checkpoint inhibitors have significantly improved the prognosis in patients with non-small cell lung cancer, compared with cytotoxic agents. However, the prediction of treatment response is often difficult, even after assessing the tu
Externí odkaz:
https://doaj.org/article/b0def5af260d4ffb910a8901979993fb
Autor:
Minehiko Inomata, Takeshi Tsuda, Tomomi Ichikawa, Masahiro Matsumoto, Isami Mizushima, Kenji Azechi, Naoki Takata, Nozomu Murayama, Kana Hayashi, Takahiro Hirai, Zenta Seto, Kotaro Tokui, Yasuaki Masaki, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Hirokazu Taniguchi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Kazuyuki Tobe
Publikováno v:
Thoracic Cancer, Vol 14, Iss 17, Pp 1618-1623 (2023)
Abstract Objective Studies have suggested the potential efficacy of immune checkpoint inhibitors (ICIs) for pulmonary sarcomatoid carcinoma. This multicenter observational study was conducted to evaluate the efficacy of systemic ICI therapy and chemo
Externí odkaz:
https://doaj.org/article/d017de19d4e6443389f1d93a76555a9a
Autor:
Minehiko Inomata, Masahiro Matsumoto, Isami Mizushima, Kana Hayashi, Zenta Seto, Kotaro Tokui, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Kazuyuki Tobe
Publikováno v:
The Egyptian Journal of Bronchology, Vol 16, Iss 1, Pp 1-7 (2022)
Abstract Purpose We conducted a retrospective analysis of the data of patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) to investigate the associations between clinical factors and the overall survival. M
Externí odkaz:
https://doaj.org/article/8f2fac69bfef4d0bbfcfa51ee111cb99
Autor:
Minehiko Inomata, Kenji Azechi, Naoki Takata, Kana Hayashi, Kotaro Tokui, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Kazuyuki Tobe
Publikováno v:
Diagnostics, Vol 10, Iss 12, p 1006 (2020)
Background: Among patients with non-small cell lung cancer (NSCLC), we compared the progression-free survival (PFS) and proportion of acquisition of T790M mutation of the epidermal growth receptor gene (EGFR) after first-line treatment with epidermal
Externí odkaz:
https://doaj.org/article/445524ef0ddf4c539f188e1e53d494d1
Autor:
Takeshi Tsuda, Kensuke Suzuki, Minehiko Inomata, Kana Hayashi, Isami Mizushima, Kotaro Tokui, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Yasuaki Masaki, Hirokazu Taniguchi, Kazuyuki Tobe
Publikováno v:
Molecular and Clinical Oncology. 18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::559dc9014f060f66b63c9f1bfbd2b304
https://doi.org/10.3892/mco.2023.2634
https://doi.org/10.3892/mco.2023.2634
Autor:
TAKAHIRO HIRAI, MINEHIKO INOMATA, SHUHEI MINATOYAMA, MOE HASHIZUME, NAOKI TAKATA, KANA HAYASHI, ZENTA SETO, KOTARO TOKUI, CHIHIRO TAKA, SEISUKE OKAZAWA, KENTA KAMBARA, SHINGO IMANISHI, TOSHIRO MIWA, RYUJI HAYASHI, SHINICHI TANAKA, AKIRA NOGUCHI, TSUTOMU SATO
Publikováno v:
In Vivo; May/Jun2024, Vol. 38 Issue 3, p1509-1511, 3p
Autor:
Naoki Takata, Kenta Kambara, Kotaro Tokui, Chihiro Taka, Seisuke Okazawa, Shingo Imanishi, Toshiro Miwa, Ryuji Hayashi, Tsutomu Sato, Hiroaki Tanaka, Minehiko Inomata
Publikováno v:
Haigan. 61:975-978
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4226e3283df28c5500e794d68e92e2e
https://doi.org/10.2482/haigan.61.975
https://doi.org/10.2482/haigan.61.975
Autor:
Mitsuhiro Nagano, Kazumasa Kamei, Hiroyuki Matsuda, Chihiro Takahashi, Jingyan Yang, Koji Wada, Naohiro Yonemoto
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 349-361 (2024)
ABSTRACTBackground The aim of this study was to evaluate the public health and economic impact of the COVID-19 booster vaccination with BNT162b2 in Japan during an Omicron-dominant period from early 2022.Research design and methods A combined cohort
Externí odkaz:
https://doaj.org/article/652a717f6bf04d74aa9b71e9676d10dc
Autor:
Ryuji Hayashi, Chihiro Taka
Publikováno v:
Nihon Naika Gakkai Zasshi. 110:534-539
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b920eb34d938a981292a5d08b87063e0
https://doi.org/10.2169/naika.110.534
https://doi.org/10.2169/naika.110.534